Till 12:35 pm; a combined 32.3 million shares representing 2.43 per cent of total equity of PPL changed hands on the NSE and BSE.

Piramal Pharma on Thursday reported over four ... the company has announced a $80 million expansion plan at the Lexington facility which is expected to be completed by the FY27 end, she added.

Piramal Pharma’s CDMO business grew due to increased demand for innovative projects, and the company also announced a $80 Million expansion plan for its Lexington plant, which is slated to be ...

Piramal Pharma is utilising a capex of about $85 million for various initiatives, including capacity expansion, maintenance and de-bottlenecking of CDMO sites, in the current fiscal, according to its ...

Piramal Pharma’s CDMO business led the growth with increased demand for generic APIs and a $80 million expansion at its Lexington facility, aimed at doubling sterile fill-finish capabilities by ...

Piramal Pharma’s CDMO business got a boost from the growing demand for innovation-driven projects. The company also unveiled an $80 million expansion plan for its Lexington facility ...

Piramal Pharma Solutions (PPS) is set to invest $80 million in expanding its sterile injectables facility in Lexington, Kentucky, USA, projected for completion by FY27. The company reported a four ...

To maintain its growth trajectory and meet rising demand for sterile fill-finish capabilities, Piramal Pharma has announced an $80-million expansion plan for its Lexington facility. This expansion ...

Piramal Pharma Ltd released its fiscal second ... we have announced a US$80 million expansion plan at our Lexington facility which is expected to get complete by the end FY27.

Piramal Pharma (PIRPHARM) delivered better-than-expected operational performance in 2QFY25 fueled by superior traction in the CDMO segment (59% of sales). Following earnings deterioration in FY23 ...

has already announced an investment of USD 80 million in expanding its sterile injectables facility in Lexington, Kentucky (US). "It will be completed in FY 27," Piramal said. Piramal Pharma is ...

we have announced a US$80Mn expansion plan at our Lexington facility which is expected to get complete by end FY27,” said ...